Baystreet Staff - Tuesday, September 2, 2025 Oncolytics Biotech Inc 09:45 AM EST - Oncolytics Biotech Inc : Provided an updated safety analysis of pelareorep, which has been administered in over 1,200 patients, including over 300 patients with various gastrointestinal tumors. Oncolytics Biotech Inc shares N.ONCY are trading up one cent at $1.05. Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=8838686149406159
